EULAV Asset Management continued to hold its position in Becton, Dickinson and Company (NYSE:BDX) during the third quarter, Holdings Channel reports. The fund owned 20,000 shares of the company’s stock at the end of the third quarter. EULAV Asset Management’s holdings in Becton, Dickinson and Company were worth $3,595,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in BDX. Jarislowsky Fraser Ltd boosted its position in Becton, Dickinson and Company by 1,050.3% in the second quarter. Jarislowsky Fraser Ltd now owns 10,373,430 shares of the company’s stock worth $531,241,000 after buying an additional 9,471,594 shares during the last quarter. BlackRock Institutional Trust Company N.A. boosted its position in Becton, Dickinson and Company by 1.4% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 5,931,754 shares of the company’s stock worth $1,066,114,000 after buying an additional 82,813 shares during the last quarter. BlackRock Fund Advisors boosted its position in Becton, Dickinson and Company by 2.8% in the third quarter. BlackRock Fund Advisors now owns 4,469,437 shares of the company’s stock worth $803,292,000 after buying an additional 123,608 shares during the last quarter. FMR LLC boosted its position in Becton, Dickinson and Company by 10.6% in the second quarter. FMR LLC now owns 2,923,810 shares of the company’s stock worth $495,850,000 after buying an additional 279,101 shares during the last quarter. Finally, Northern Trust Corp boosted its position in Becton, Dickinson and Company by 2.5% in the third quarter. Northern Trust Corp now owns 2,657,873 shares of the company’s stock worth $477,701,000 after buying an additional 64,189 shares during the last quarter. Hedge funds and other institutional investors own 81.18% of the company’s stock.

Institutional Ownership by Quarter for Becton, Dickinson and Company (NYSE:BDX)

Shares of Becton, Dickinson and Company (NYSE:BDX) traded up 0.17% on Friday, hitting $173.78. 380,334 shares of the stock traded hands. Becton, Dickinson and Company has a 52-week low of $129.50 and a 52-week high of $181.76. The stock’s 50 day moving average price is $167.40 and its 200 day moving average price is $172.31. The stock has a market cap of $36.90 billion, a P/E ratio of 38.70 and a beta of 1.00.

Becton, Dickinson and Company (NYSE:BDX) last posted its quarterly earnings results on Thursday, November 3rd. The company reported $2.12 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.09 by $0.03. The company had revenue of $3.23 billion for the quarter, compared to the consensus estimate of $3.22 billion. Becton, Dickinson and Company had a net margin of 7.82% and a return on equity of 24.45%. The firm’s revenue was up 5.6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.94 EPS. On average, equities analysts expect that Becton, Dickinson and Company will post $9.47 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, December 30th. Investors of record on Friday, December 9th were paid a $0.73 dividend. This represents a $2.92 annualized dividend and a yield of 1.68%. The ex-dividend date was Wednesday, December 7th. This is an increase from Becton, Dickinson and Company’s previous quarterly dividend of $0.66. Becton, Dickinson and Company’s dividend payout ratio (DPR) is currently 64.75%.

ILLEGAL ACTIVITY WARNING: “EULAV Asset Management Maintains Position in Becton, Dickinson and Company (BDX)” was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this piece of content can be accessed at http://www.dailypolitical.com/2017/01/13/eulav-asset-management-maintains-position-in-becton-dickinson-and-company-bdx.html.

A number of equities analysts have issued reports on BDX shares. Zacks Investment Research cut shares of Becton, Dickinson and Company from a “buy” rating to a “hold” rating in a research report on Wednesday, November 16th. Raymond James Financial, Inc. restated an “outperform” rating and issued a $180.00 price objective (down previously from $200.00) on shares of Becton, Dickinson and Company in a research report on Thursday, January 5th. Citigroup Inc. cut shares of Becton, Dickinson and Company from a “neutral” rating to a “sell” rating and reduced their price target for the company from $167.00 to $165.00 in a research report on Friday, September 23rd. Leerink Swann reiterated a “market perform” rating and set a $185.00 price target (up previously from $180.00) on shares of Becton, Dickinson and Company in a research report on Monday, November 21st. Finally, RBC Capital Markets reiterated a “hold” rating and set a $177.00 price target on shares of Becton, Dickinson and Company in a research report on Friday, January 6th. One analyst has rated the stock with a sell rating, eight have given a hold rating and seven have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $176.39.

In related news, VP John E. Gallagher sold 1,793 shares of the firm’s stock in a transaction dated Thursday, December 15th. The shares were sold at an average price of $168.82, for a total value of $302,694.26. Following the transaction, the vice president now owns 2,796 shares of the company’s stock, valued at approximately $472,020.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Stephen Sichak sold 2,632 shares of the firm’s stock in a transaction dated Monday, December 5th. The stock was sold at an average price of $164.44, for a total transaction of $432,806.08. Following the completion of the transaction, the insider now directly owns 7,953 shares in the company, valued at approximately $1,307,791.32. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by corporate insiders.

About Becton, Dickinson and Company

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

5 Day Chart for NYSE:BDX

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.